Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma

BACKGROUND: Cuproptosis was recently recognized as a novel form of cell death, linked closely to the occurrence and progression of cancer. We aimed to identify prognostic cuproptosis-related long noncoding RNAs (lncRNAs) and build a risk signature to predict the prognosis and treatment responses of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haoxun, Ning, Zikuan, Wang, Bowen, Liu, Yiwen, Tao, Boju, Zhang, Guoling, Liu, Hua, Wang, Chunyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893525/
https://www.ncbi.nlm.nih.gov/pubmed/36741910
http://dx.doi.org/10.1155/2023/7219794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893525/
https://www.ncbi.nlm.nih.gov/pubmed/36741910
http://dx.doi.org/10.1155/2023/7219794

Ejemplares similares